Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Skylight Health Group Inc V.SLHG.H

Alternate Symbol(s):  SLHGF

Skylight Health Group Inc. is a Canada-based healthcare services and technology company. The Company operates a Florida-based primary care health network comprised of physical practices providing a range of services from primary care, sub-specialty, allied health and laboratory/diagnostic testing. The Company is focused on helping small and independent practices shift from a traditional fee-for-service (FFS) model to value-based care (VBC) through tools, including proprietary technology, data analytics and infrastructure. The Company has two segments related to its medical services and software and corporate businesses, which also align with the two countries in which it operates, namely, United States and Canada. It provides a range of healthcare services, including primary and urgent care, sub-specialists, allied health and wellness, and laboratory/diagnostic testing.


TSXV:SLHG.H - Post by User

Comment by SecurityNetworkon Mar 01, 2023 12:08am
193 Views
Post# 35311555

RE:STSS unknown 10 month IPO

RE:STSS unknown 10 month IPO

Braden Miller, Sharps Director of Product Management, commented, “Sharps has developed a high-quality alternative solution to glass syringes through the use of inert polymers such as Cyclic Olefin Polymer (COP) and Cyclic Olefin Copolymer (COC), which offers a high-quality solution compared to traditional glass syringe systems.”

Sharps' specialized product pipeline and market strategy will include a broad range of sizes, silicon-free systems that address contamination issues for the broader healthcare market, dual chamber systems that improve drug shelf life while reducing unnecessary packaging, and customized solutions for systems that serve the growing autoinjector segment.

<< Previous
Bullboard Posts
Next >>